ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression
Matthew A. Spear, Larry Alphs, Shaohui Wu, G. Wang et al.
Citations
5 citations
Journal
JAMA Psychiatry
Topics
Pharmaceutical studies and practices
Field-Weighted Citation Impact (FWCI)
17.47
article
ANK3 as a Novel Genetic Biomarker for Liafensine in Treatment-Resistant Depression
Matthew A. Spear, Larry Alphs, Shaohui Wu, G. Wang, Charles B. Nemeroff, Ashok R. Patel, Shikai Wang, Anning Li, Xiaoxiong Lu, Crystal Chen, Holly Huang, Mario Aguado, Julie Doostzadeh, Wen Luo, Zhiqiang Wang
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
JAMA PsychiatryVol. 82(12)
Institutions
Capital Medical University (CN), Beijing Anding Hospital (CN), Jiangxi Mental Health Center (CN), RG Biopharma (United States) (US), Third People's Hospital of Huzhou (CN), Advanced Memory Research Institute of New Jersey (US), School of Clinical Research (US), The University of Texas at Austin (US)